Trillium Therapeutics Inc. ( TRIL) - Stock Earnings
Stock symbol TRIL is outdated, potentially delisted? Maybe it is available on other exchange?
TRIL Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2021Q1 | -10.9 million USD | 0 USD |
| 2021Q2 | -18.4 million USD | 10000 USD |
| 2021Q3 | -19.3 million USD | 0 USD |
TRIL Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2018 | -32.9 million USD | 0 USD |
| 2019 | -38.1 million USD | 124000 USD |
| 2020 | -59.3 million USD | 148000 USD |
TRIL
Price: $18.44
52 week price:
Dividend Yield: 5.56%
Earnings Per Share: -2.92 USD
P/E Ratio: -10.91
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 26.2 million
Ebitda: -8.2 millionMarket Capitalization: 1.9 billion